Paediatric medicines research in the UK: How to move forward?

Drug Safety

Volumn 26, Issue 8, 2003, Pages 529-537

  Wong, Ian ^a,b   Sweis, Dimah ^a   Cope, Judith ^c   Florence, Alexander ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; CHILD HEALTH CARE; COHORT ANALYSIS; DRUG LABELING; DRUG MONITORING; DRUG RESEARCH; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; HEALTH CARE PERSONNEL; HUMAN; LICENSING; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UNITED KINGDOM;

CHILD; CLINICAL TRIALS; DRUG INFORMATION SERVICES; DRUG LABELING; GREAT BRITAIN; HUMANS; PEDIATRICS; PHARMACEUTICAL PREPARATIONS; PRESCRIPTIONS, DRUG; RESEARCH;

EID: 0037635309     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200326080-00001     Document Type: Review

References (45)

1. Gospel according to Luke. New Testament. Holy Bible
2. Parental Media Guide [online]. Available from URL: http://www.parentalguide.org/ [Accessed 2003 May 2]
3. Turner S, Longworth A, Nunn AJ, et al. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ 1998; 316:343-5
4. Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ 2000; 320:79-82
5. Bücheler R, Schwab M, Mörike K, et al. Off label prescribing to children in primary care in Germany: retrospective cohort study. BMJ 2002; 342: 1311-2
6. Schirm E, Tobi H, de Jong-van den Berg TW. Unlicensed and off label drug use by children in the community: cross sectional study. BMJ 2002; 324: 1312-3
7. t'Jong GW, Eland IA, Sturkenboom MCJM, et al. Unlicensed and off label prescription of drugs to children: population based cohort study. BMJ 2002; 324: 1313-4
8. Steinbrook R. Testing medications in children. N Engl J Med 2002; 347 (18): 1462-70
9. Parliament, UK. Medicines (children), in House of Commons Hansard debates. Bound volume debates. Vol. 329, Column 669, April 19, 1999
10. Turner S, Nunn AJ, Fielding K, et al. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr 1999; 88 (9): 965-8
11. Regulations Requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients: final rule. Federal Register 1998: 66631-66673
12. Best Pharmaceuticals for Children Act [online]. Available from URL:http://frwebgate.access.gpo.gov/cgibin/useftp.cgi [Accessed 2003 Mar 3]
13. Proposed regulatory actions on paediatric medicinal products, in better medicines for children. 2002: European Commission, Brussels [online]. Available from URL: http: //www.pharmacos.eudra.org/F2/pharmacos/medchild.htm [Accessed 2003 Mar 3]
14. Medicines and Healthcare Products Regulatory Agency [online]. Available from URL: http://www.mhra.gov.uk/aboutm-hra/aboutmhra.htm [Accessed 2003 May 6]
15. Sweis D, Wong I. Electronic response: where do our interests lie? e-BMJ [online]. Available from URL: http://bmj.com/cgi/eletters/324/7349/1290#23972 [Accessed 2003 Mar 3]
16. Pediatric Pharmacology Research Unit Network. Release date: November 18, 2002 RFA: HD-03-001 [online]. Available from URL: http://www.grants1.nih.gov/grants/guide/rfa-files/RFA-HD-03-001.html [Access 2003 Mar 3]
17. Overview of comments on consultation paper "Better Medicines for Children" 2002: European Commission, Brussel. [online]. Available from URL: http: //pharmacos.eudra.org/F2/pharmacos/medchild.htm [Accessed 2003 Mar 3]
18. Choonara I. Clinical trials of medicines in children. BMJ 2000; 321 (7269): 1093-4
19. Conroy S, McIntyre J, Choonara I, et al. Drug trials in children: problems and the way forward. Br J Clin Pharmacol 2000; 49 (2): 93-7
20. Stephenson T, Walker DA. Telling parents all relevant details might reduce recruitment of children to trials. BMJ 1996; 313 (7053): 362-3
21. Clinical Trials. EU Directive on Good Clinical Practice in clinical trials [online]. Available from URL: http://www.mca.gov.uk/ourwork/licensingmeds/types/clintrialsconsult.htm [Accessed 2003 Mar 3]
22. Royal College of Paediatrics and Child Health and Neonatal and Paediatric Pharmacists Group. Unlicensed medicines in paediatric practice. Medicines for Children. London; RCPCH Publications Ltd, 1999: xiii
23. Federal Register [online]. Available from URL: http://www.fda.gov/ohrms/dockets/98fr/120298c.txt [Accessed 2003 Mar 3]
24. Committee for Proprietary Medicinal Products (CPMP). ICH Efficacy Topics: E11. Clinical Investigation of medicinal products in the pediatric population. International Conference on Harmonisation; 2000 July 27: London. Available from URL: http://www.emea.eu.int/pdfs/human/ich/271199EN.pdf [Accessed 2003 Mar 3]
25. Wong ICK. Pharmacovigilance resources in the United Kingdom. Pharm J 1999; 263: 285-8
26. Wong ICK, Sweis D. Techniques in pharmacovigilance. Pharm J 2000; 264: 922-3
27. Baud O, Foix-L'Helias L, Kaminski M, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999; 341 (16): 1190-6
28. Lesko SM, O'Brien KL, Schwartz B, et al. Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella. Pediatrics 2001; 107 (5): 1108-15
29. de Vathaire F, Hawkins M, Campbell S, et al. Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer 1999; 79 (11-12): 1884-93
30. Clarkson A, Ingleby E, Choonara I, et al. A novel scheme for the reporting of adverse drug reactions. Arch Dis Child 2001; 84 (4): 337-9
31. Britton A, McKee M, Black N, et al. Choosing between randomized and non-randomised studies: a systematic review. Health Technol Assess 1998; 2 (13): 1-124
32. Padkin A, Rowan K, Black N. Using high quality databases to complement the results of randomised controlled trials: the case of recombinant activated protein C. BMJ 2001; 323: 923-6
33. Committee on Drugs, American Academy of Pediatrics. Use of drug not described in the package insert (off-label uses). Pediatrics 2002; 110 (1): 181-3
34. Standing Medical Advisory Committee Advice. Licensing and prescribing of drugs in children (5/2001) [online]. Available from URL: http: //www.doh.gov.uk/smacdrugschildren.htm [Accessed 2003 Mar 3]
35. Okuonghae HO, Ighogboja IS, Lawson JO, et al. Diethylene glycol poisoning in Nigerian children. Ann Trop Paediatr 1992; 12 (3): 235-8
36. Hanif M, Mobarak MR, Ronan A, et al. Fatal renal failure caused by diethylene glycol in paracetamol elixir: the Bangladesh epidemic. BMJ 1995; 311: 88-91
37. O'Brien KL, Selanikio JD, Hecdivert C, et al. Epidemic of pediatric deaths from acute renal failure caused by diethylene glycol poisoning. JAMA 1998; 379: 1175-80
38. Gershanik J, Boecler B, Ensley H, et al. The gasping syndrome and benzyl alcohol poisoning. N Engl J Med 1982; 307: 1384-8
39. Phelps DL. E-Ferol: What happened and what now? Pediatr 1984; 74: 1114-6
40. Martin-Bouyer G, Lebreton R, Toga M, et al. Outbreak of accidental hexachlorophene poisoning in France. Lancet 1982; I (8623): 91-5
41. Powell H, Swarner O, Gluck L, et al. Hexachlorophene myelinopahty in premature infants. J Pediatr 1973; 82: 976-81
42. Wong ICK. Researching better medicines for children - a collaborative approach. Pharmaceutical Journal 2003; 270: 549-50. Available from URL: http://www. pharmj.com/pdf/agenda/pj_20030419_children.pdf [Accessed 2003 May 7]
43. Bonati M, Choonara I, Hoppu K, et al. Closing the gap in drug therapy [letter]. Lancet 1999; 353 (9164): 1625
44. General Paediatric Competencies [online]. Available from URL: http://www.collpharm.org.uk/FNPPCompetencies.PDF [Accessed 2003 Mar 3]
45. Department of Health. Getting the right start: National Service Framework for Children - Standard for Hospital Services. HMSO 2003 London. Available from URL: http://www.doh.gov.uk/nsf/children/standardhospserviceindex.htm [Accessed 2003 May 6]